Treatment of Meniere's Disease With Migraine Medications
Status:
Recruiting
Trial end date:
2024-08-01
Target enrollment:
Participant gender:
Summary
Meniere's disease (MD) is a chronic disease with a variety of fluctuating signs and symptoms,
which include vertigo, hearing loss, tinnitus (ringing noise in the ear), aural pressure
(feeling of ear fullness), and disequilibrium (lack of stability). Vertigo represents one of
the most common and distressing problems in MD patients, and it causes various somatic and
psychological disorders that interfere with the patient's quality of life. Despite the large
economic and emotional impact of symptoms in MD patients, there is no FDA-approved medication
to treat this debilitating condition. As such, our objective in this study is to evaluate the
therapeutic potential of novel medications in treating MD that have previously shown
astonishing promise in our clinical practice.